Assurant, Inc. (AIZ) — Fair Value Analysis

Base-case fair value (P50): $209.23 · Current price: $255.63 · Verdict: Overvalued

The Verdict on AIZ

Our Monte Carlo simulations indicate Assurant (AIZ) is currently overvalued, with its shares trading at $255.63 compared to a median fair value (P50) of $209.23. This gap suggests a notable -18.2% downside based on our forward-looking model. The 'Overvalued' verdict stems directly from the probabilistic outcomes of thousands of simulated scenarios, highlighting a significant divergence between AIZ's market capitalization and its intrinsic value potential. Investors considering AIZ at its $255.63 should acknowledge this substantial valuation premium relative to our fair value estimate of $209.23.

How AIZ stacks up against Financial Services

Within the Financial Services sector, Assurant (AIZ) presents a unique profile. While its operational and financial health is currently unrated by our quality tier assessment, the pronounced disparity between its $255.63 and our $209.23 median fair value remains a critical factor. This valuation suggests that the market may be pricing in growth or stability expectations that are not fully supported by our quantitative analysis, which considers the inherent volatility and opportunities within its sector. The -18.2% difference underscores the elevated risk for new positions at the current valuation.

What this means for investors

For investors, the 'Overvalued' verdict on AIZ, driven by the significant -18.2% gap between $255.63 and the $209.23 fair value, points to a potentially unattractive entry point. Our Monte Carlo simulations consistently place the stock's current price above its fundamental fair value range. While bull-case scenarios exist, the baseline analysis strongly suggests a downward re-rating is more likely given the current spread. To explore the full distribution of bear and bull case targets, sign up for a free FairCurve account and track AIZ's fair value as new fundamentals are released.